Promethera Biosciences' Convertible Note Round

Promethera Biosciences raised a round of funding on April 10, 2018.

Promethera Biosciences is a pharmaceutical company that develops therapies for the treatment of liver disease. It is developing products based on a newly discovered and patented cell, the Heterologous…

Articles about Promethera Biosciences' Convertible Note Round: